ArticleArthroplasty (London, England)2025
Chronic preoperative steroid use and total shoulder arthroplasty: a propensity score matched analysis of early-onset infectious outcomes.
Article in Arthroplasty (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile the role of chronic preoperative steroid use in orthopedic outcomes has been studied, particularly in hip, knee, and lumbar surgeries, its impact on total shoulder arthroplasty (TSA) outcomes is not well understood. This study aimed to evaluate the impact of chronic preoperative steroid use on early-onset postoperative infectious outcomes and readmission within 30 days following TSA compared to patients without chronic steroid use.
methodsA retrospective analysis was performed using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) spanning from 2010-2018. Clinical data including preoperative demographics, operative variables, and 30-day post-TSA outcomes were collected. Groups were balanced using propensity score matching based on gender, age, race, ethnicity, BMI, functional status, ASA, smoking status, alcohol use, year of operation, and comorbidities. A conditional logistic regression model was used to calculate odds ratios for each outcome measure.
resultsA total of 3,445 identified cases were included in this analysis after propensity score matching, with 1,157 exhibiting chronic steroid use. The steroid group demonstrated significantly greater rates of readmission (OR: 1.86; 95% CI: 1.22-2.81; P = 0.004). No significant differences were observed between groups in all other adverse outcomes, including reoperation, specific infectious outcomes, and combined infectious outcomes.
conclusionsPreoperative chronic steroid use is an independent predictor of readmission but not infection following TSA. While the surgeon should be aware of the increased risk of readmission associated with chronic steroid use, the role of steroid use as a risk factor for postoperative infections following TSA may be less pronounced, particularly compared to surgeries of other joints. Further investigation of infectious outcomes and readmissions with longer follow-up is needed to clarify the specific role of chronic preoperative steroid use in adverse outcomes following TSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.